Американское общество гирудотерапии

Cubital Tunnel Syndrome (Investigational Adjunct)

Investigational adjunct for mild cubital tunnel syndrome; elbow extension splinting and ergonomic modification remain first-line; surgical decompression for moderate-severe cases.

Tier C — InvestigationalИсследовательское применениеLast updated: 2026-05-26 · Reviewed by ASH Editorial Board

Краткая информация для пациента

Есть ли FDA-допуск для этого показания?
Not FDA-cleared for cubital tunnel syndrome. FDA cleared medicinal leeches only for venous congestion in microsurgical reconstruction (K040187, 2004). Use here is investigational.
Какие доказательства существуют?
Tier C (investigational). There are no published controlled trials for cubital tunnel syndrome. Evidence-based first-line care for mild sensory-only disease is nocturnal elbow extension splinting (the strongest non-operative evidence), ergonomic modification (avoiding prolonged elbow flexion, padding elbows from direct pressure), and physical therapy with nerve and tendon gliding exercises. Electrodiagnostic testing stages severity. Moderate-to-severe disease, motor weakness, or intrinsic hand atrophy require surgical decompression - in-situ release, anterior transposition (submuscular or subcutaneous), or medial epicondylectomy.
Основные риски
  • Bleeding from the bite site for 6 to 24 hours after detachment
  • Bruising over the medial elbow for 5 to 10 days
  • Local skin or, rarely, Aeromonas hydrophila infection
  • Allergic reaction to leech saliva (uncommon)
  • Worsening ulnar paresthesia from local tissue swelling near the nerve
  • RISK of ulnar nerve trauma if leech is placed directly over the cubital tunnel or ulnar nerve groove behind the medial epicondyle
  • Delay of surgical decompression in patients with motor weakness who need it
Кому не следует это рассматривать
  • Patients with intrinsic hand muscle weakness or atrophy (this needs surgical decompression)
  • Patients with moderate-to-severe electrodiagnostic findings
  • Patients who have not tried at least 8 weeks of nocturnal elbow-extension splinting and ergonomic modification
  • Patients who have had prior ulnar nerve transposition surgery (anatomy is altered)
  • Patients with cervical radiculopathy (C8-T1) mimicking cubital tunnel - imaging must distinguish
  • Patients on anticoagulants, with hemophilia, or with severe anemia
  • Patients with active dermatitis or broken skin over the medial elbow
О чём спросить врача
  • Have I had electrodiagnostic testing (nerve conduction studies) to stage the disease?
  • Have I been worked up for cervical radiculopathy (C8-T1) and thoracic outlet syndrome as alternatives?
  • Have I tried at least 8 weeks of nocturnal elbow-extension splinting and ergonomic modification?
  • Do I have motor weakness or intrinsic hand atrophy that requires surgical decompression?
  • Where exactly will the leech be placed - confirm it is NOT directly over the ulnar nerve groove behind the medial epicondyle?
  • What is the practitioner's experience with this nerve specifically, and stopping rules if symptoms worsen?
  • What is the Aeromonas-prevention protocol?
Когда срочно обратиться за медицинской помощью
  • Sudden severe ulnar-distribution weakness, inability to abduct or adduct fingers, or hand atrophy
  • Sudden loss of sensation in the small and ring fingers
  • Acute swelling, severe pain, or cold pallor of the hand or forearm
  • Bleeding from the bite site lasting more than 24 hours
  • Fever, chills, or spreading redness at the bite site
  • Hives, facial or throat swelling, or breathing difficulty

Что это НЕ означает

  • This is not FDA-cleared for cubital tunnel syndrome.
  • It does not address motor weakness or hand atrophy, both of which require surgical decompression.
  • It does not replace nocturnal elbow extension splinting and ergonomic modification, which are the strongest mild-disease evidence interventions.
  • It is not placed directly over the ulnar nerve groove - that risks nerve trauma.
  • Only anecdotal evidence exists; no controlled trials support efficacy.

Clinical Profile

Category
neurological
ICD-10
G56.20, G56.21, G56.22
Safety tier
medium

Evidence Summary

Cubital tunnel syndrome (ulnar neuropathy at the elbow) presents with paresthesia in the ulnar nerve distribution and (in advanced cases) intrinsic hand weakness. Evidence-based first-line management for mild disease is nocturnal elbow extension splinting, ergonomic modification (avoiding prolonged elbow flexion and direct pressure), and physical therapy. Electrodiagnostic testing stages severity. Moderate-to-severe disease or motor involvement requires surgical decompression (in situ release, transposition). No published controlled trials of hirudotherapy exist for cubital tunnel syndrome. Anecdotal reports describe medial elbow application with subjective relief in mild cases. Direct placement over the cubital tunnel risks ulnar nerve trauma.

Treatment specifics

How many leeches, where they are placed, how long a session lasts, and whether to repeat are clinical decisions made by a qualified provider under institutional protocol — not something to self-administer. Discuss the specifics with a clinician experienced in medicinal leech therapy. (Clinicians: switch the audience selector in the top bar to “Clinician” to view protocol detail.)

Contraindications

  • Active anticoagulant therapy (warfarin INR >2.0, DOACs, heparin)
  • Hemophilia or other bleeding disorder
  • Severe anemia (Hb <10 g/dL)
  • Active bacteremia or sepsis
  • Known hypersensitivity to leech salivary proteins
  • Pregnancy (relative — first/third trimester)
  • Immunocompromised state with severe neutropenia
  • Motor weakness or intrinsic hand atrophy (surgical referral)
  • Moderate-to-severe electrodiagnostic findings
  • Direct placement over the cubital tunnel or ulnar nerve groove
  • Prior ulnar nerve transposition surgery
  • Cervical radiculopathy mimicking cubital tunnel (workup first)

Related Conditions

Этот сайт предоставляет образовательную информацию и не является медицинской консультацией, диагнозом или рекомендацией по лечению. Гирудотерапия сопряжена с клинически значимыми рисками и должна проводиться только квалифицированными клиницистами в рамках институционально утверждённых протоколов. Разрешение FDA 510(k) для медицинских пиявок ограничено определёнными показаниями; обсуждения исследовательского и нелицензионного применения отмечены соответствующим образом. Для индивидуальных медицинских рекомендаций обратитесь к квалифицированному медицинскому специалисту.

Cubital Tunnel Syndrome (Investigational Adjunct) — Hirudotherapy Evidence | ASH